The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Effect of dual properties of regorafenib in osteosarcoma on tumor progression and bone parameters in mouse preclinical models.
 
Javier Munoz Garcia
No Relationships to Disclose
 
Jorge William Vargas-Franco
No Relationships to Disclose
 
Emmanuelle Bompas
No Relationships to Disclose
 
Denis Cochonneau
No Relationships to Disclose
 
Emilie Ollivier
No Relationships to Disclose
 
Jerome Kerzerho
Employment - Hephaistos Pharma
Leadership - Hephaistos Pharma
Stock and Other Ownership Interests - Hephaistos Pharma
Honoraria - Hephaistos Pharma
Research Funding - Hephaistos Pharma
Travel, Accommodations, Expenses - Hephaistos Pharma
 
Mehdi Brahmi
Honoraria - Deciphera; PharmaMar
Travel, Accommodations, Expenses - PharmaMar
 
Jean-Yves Blay
Leadership - Innate Pharma
Honoraria - AstraZeneca; Bayer; BMS; Deciphera; Ignyta; MSD; PharmaMar; Roche
Consulting or Advisory Role - Bayer; Blueprint Medicines; Deciphera; Deciphera; Deciphera; Deciphera; Karyopharm Therapeutics; Pharmamar; Roche
Research Funding - AstraZeneca (Inst); Bayer (Inst); BMS (Inst); DEciphera (Inst); GlaxoSmithKline (Inst); MSD (Inst); Novartis (Inst); OSE Pharma (Inst); Pharmamar (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Roche
 
Maire-Francoise Heymann
No Relationships to Disclose
 
Frederic Lezot
No Relationships to Disclose
 
Dominique Heymann
Stock and Other Ownership Interests - Atlanta Group
Honoraria - Bayer
Research Funding - AstraZeneca; Bayer
Travel, Accommodations, Expenses - Bayer